Steven E. Scherer

44.7k total citations
37 papers, 1.9k citations indexed

About

Steven E. Scherer is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Steven E. Scherer has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in Steven E. Scherer's work include Pharmacogenetics and Drug Metabolism (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Epigenetics and DNA Methylation (4 papers). Steven E. Scherer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Epigenetics and DNA Methylation (4 papers). Steven E. Scherer collaborates with scholars based in United States, Italy and Canada. Steven E. Scherer's co-authors include Richard A. Gibbs, Gábor Veres, C. Thomas Caskey, Dianna M. Milewicz, Shuangxing Yu, Russell R. Broaddus, Karen H. Lu, Gordon B. Mills, Lydia W.T. Cheung and Yiling Lu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Steven E. Scherer

36 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven E. Scherer United States	19	906	466	326	303	276	37	1.9k
Avinash Abhyankar United States	20	959 1.1×	650 1.4×	173 0.5×	124 0.4×	132 0.5×	30	1.9k
Katherine Gowan United States	21	1.2k 1.3×	212 0.5×	274 0.8×	166 0.5×	237 0.9×	32	2.2k
Paul Kiefer Germany	27	1.4k 1.5×	217 0.5×	139 0.4×	142 0.5×	216 0.8×	53	2.3k
Michael Rauchman United States	27	1.6k 1.8×	355 0.8×	337 1.0×	122 0.4×	86 0.3×	43	2.4k
Bernd Kinzel Switzerland	23	1.4k 1.5×	183 0.4×	379 1.2×	123 0.4×	168 0.6×	30	2.1k
Weizhen Ji United States	14	1.9k 2.0×	1.1k 2.3×	198 0.6×	257 0.8×	301 1.1×	47	3.3k
Hiroko Morisaki Japan	25	1.1k 1.2×	814 1.7×	488 1.5×	423 1.4×	143 0.5×	105	2.4k
Ken‐ichirou Morishige Japan	27	1.2k 1.3×	138 0.3×	163 0.5×	277 0.9×	307 1.1×	90	2.4k
Reiko Kurotani Japan	23	879 1.0×	262 0.6×	340 1.0×	108 0.4×	151 0.5×	57	1.7k
Steven M. Harrison United States	22	1.5k 1.6×	1.7k 3.6×	158 0.5×	264 0.9×	443 1.6×	52	3.2k

Countries citing papers authored by Steven E. Scherer

Since Specialization

Citations

This map shows the geographic impact of Steven E. Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Scherer more than expected).

Fields of papers citing papers by Steven E. Scherer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Scherer. The network helps show where Steven E. Scherer may publish in the future.

Co-authorship network of co-authors of Steven E. Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Scherer. A scholar is included among the top collaborators of Steven E. Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Scherer. Steven E. Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaedigk, Andrea, Erin C. Boone, Steven E. Scherer, et al.. (2022). CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis. Journal of Molecular Diagnostics. 24(4). 337–350. 28 indexed citations

Alge, Joseph L., et al.. (2022). Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood. Pediatric Nephrology. 38(3). 687–695. 6 indexed citations

Peterson, Sandra E., Katrina E. Kotzer, Guilherme S. Lopes, et al.. (2022). Targeted Genotyping in Clinical Pharmacogenomics. Journal of Molecular Diagnostics. 24(3). 253–261. 22 indexed citations

Moon, Irene, Ming‐Fen Ho, Nicholas B. Larson, et al.. (2019). Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19. Drug Metabolism and Disposition. 47(4). 425–435. 16 indexed citations

Webb, Amy, Yan Gong, Caitrin W. McDonough, et al.. (2018). Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies. BMC Medical Genomics. 11(1). 55–55. 7 indexed citations

Liu, Duan, Ming‐Fen Ho, Daniel J. Schaid, et al.. (2017). Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes. npj Breast Cancer. 3(1). 30–30. 11 indexed citations

Webb, Amy, Yan Gong, Caitrin W. McDonough, et al.. (2017). Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics. Scientific Reports. 7(1). 16068–16068. 6 indexed citations

Tanner, Julie‐Anne, Andy Z. X. Zhu, Katrina G. Claw, et al.. (2017). Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenetics and Genomics. 28(1). 7–16. 18 indexed citations

McGuire, Amy L., Quianta Moore, Mary A. Majumder, et al.. (2016). The ethics of conducting molecular autopsies in cases of sudden death in the young. Genome Research. 26(9). 1165–1169. 13 indexed citations

10.

Lotta, Luca A., Giacomo Tuana, Jin Yu, et al.. (2013). Next‐generation sequencing study finds an excess of rare, coding single‐nucleotide variants of ADAMTS13 in patients with deep vein thrombosis. Journal of Thrombosis and Haemostasis. 11(7). 1228–1239. 42 indexed citations

11.

Murphy, Stephen J., Steven N. Hart, Joema Felipe Lima, et al.. (2013). Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor. Gastroenterology. 145(5). 1098–1109.e1. 140 indexed citations

12.

Lotta, Luca A., Mark L. Wang, Jin Yu, et al.. (2012). Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. BMC Medical Genomics. 5(1). 7–7. 29 indexed citations

13.

Eppsteiner, Robert W., A. Eliot Shearer, Michael S. Hildebrand, et al.. (2012). Prediction of cochlear implant performance by genetic mutation: The spiral ganglion hypothesis. Hearing Research. 292(1-2). 51–58. 108 indexed citations

14.

Cheung, Lydia W.T., Bryan T. Hennessy, Jie Li, et al.. (2011). High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability. Cancer Discovery. 1(2). 170–185. 352 indexed citations

15.

Pannu, H., Van Tran‐Fadulu, Christina L. Papke, et al.. (2007). MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Human Molecular Genetics. 16(20). 2453–2462. 195 indexed citations

16.

Zhao, Yang, Neil E. Bowles, Steven E. Scherer, et al.. (2006). Desmosomal Dysfunction due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Circulation Research. 99(6). 646–655. 223 indexed citations

17.

Yoon, Dong Sup, Li Li, Andrzej Kram, et al.. (2001). Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. Oncogene. 20(36). 5005–5014. 25 indexed citations

18.

Chew, Li‐Jin, Xiaoqing Yuan, Steven E. Scherer, et al.. (2001). Characterization of the Rat GRIK5 Kainate Receptor Subunit Gene Promoter and Its Intragenic Regions Involved in Neural Cell Specificity. Journal of Biological Chemistry. 276(45). 42162–42171. 15 indexed citations

19.

Kram, Andrzej, Li Li, Dong Sup Yoon, et al.. (2001). Mapping and Genome Sequence Analysis of Chromosome 5 Regions Involved in Bladder Cancer Progression. Laboratory Investigation. 81(7). 1039–1048. 26 indexed citations

20.

Scherer, Steven E., Gábor Veres, & C. Thomas Caskey. (1988). The genetic structure of mouse ornithine transcarbamylase. Nucleic Acids Research. 16(4). 1593–1601. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact